FGFR4-IN-24
FGFR4-IN-24 is a selective irreversible covalent FGFR4 inhibitor (IC50 = 1.2 nM). FGFR4-IN-24 shows much weaker activity against the other three FGFR family kinases (FGFR1-3). FGFR4-IN-24 inhibits the FGF19/FGFR4 signaling pathway, effectively suppressing the proliferation of the HuH-7 HCC cell line (GI50 = 17 nM). FGFR4-IN-24 exhibits significant antitumor activity in a HuH-7 mouse xenograft model. FGFR4-IN-24 can be used for the research of hepatocellular carcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3053546-73-6
- 分子式: C27H22FN5O3
- 分子量:483.49
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
IC50 & Target
[1]|
FGFR4 1.2 nM (IC50) |
体外実験
FGFR4-IN-24 (Compound 10v) (3 nmol/L, 0-30 min) shows a time-dependent enhancement in apparent inhibitory activity with prolonged preincubation, consistent with its ability to covalently modify FGFR4[1].
FGFR4-IN-24 (kinact/KI = 4.8 × 105 M-1s-1) exhibits superior potency, mainly due to its tighter binding to FGFR4 kinase (KI = 0.62 nM) from a binding mode that boosts noncovalent affinity[1].
FGFR4-IN-24 (72 h) inhibits the proliferation of HuH-7 cell line (IC50 = 1.2 nM, GI50 = 17 nM)[1].
FGFR4-IN-24 (1 μM) exhibits substantial inhibition of FGFR4 (79%) with high selectivity[1].
FGFR4-IN-24 (1-1000 nM, 2 h) inhibits the phosphorylation of the FGFR4 substrate FRS2α and reduces the phosphorylation levels of ERK in HuH-7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HuH-7 cells
-
Concentration:
-
Incubation Time:72 h
-
Result:Induced a growth inhibition 50% (GI50) of 17 nM.
-
Cell Line:HuH-7 cells
-
Concentration:1, 3, 10, 30, 100, 300, 1000 nM
-
Incubation Time:2 h
-
Result:Inhibited almost completely the phosphorylation of FRS2α at 100 nM.
Reduced the phosphorylation levels of ERK.
Maintained the inhibition of FRS2α and ERK phosphorylation at 300 nM even after extensive washing with phosphate-buffered saline (PBS) (HY-K3005).
Parmacokinetics
| Species | Dose | Route | T1/2 | MRT | Vz | Vss | CL | Cmax | AUC0-t | AUC0-∞ | Bioavailability | Tmax |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 2 mg/kg | i.v. | 0.5 h | 0.3 h | 0.37 L/kg | 0.15 L/kg | 8.28 mL/min/kg | 17449 ng/mL | 4143 ng·h/mL | 4147 ng·h/mL | / | / |
| Mice[1] | 5 mg/kg | i.p. | 12.7 h | 4.87 h | / | / | / | 2377 ng/mL | 10331 ng·h/mL | 12421 ng·h/mL | 120 % | 0.83 h |
| Mice[1] | 5 mg/kg | p.o. | 0.98 h | 0.74 h | / | / | / | 65.8 ng/mL | 55.2 ng·h/mL | 75.4 ng·h/mL | 0.73 % | 0.25 h |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:HuH-7 xenograft mouse model in female BALB/c nude mice (4 weeks)[1]
-
Dosage:25, 50 mg/kg
-
Administration:Intraperitoneal administration (i.p.), twice daily for 21 days
-
Result:Significantly inhibited tumor growth at 25 mg/kg, with a tumor growth inhibition (TGI) ratio of 85%.
Caused tumor regression at 50 mg/kg, with a TGI ratio of 114%.
Induced no significant reduction in body weight.
化学情報
-
CAS 番号 3053546-73-6
-
分子量 483.49
-
分子式 C27H22FN5O3
-
SMILES
C=CC(NC1=CC=CC=C1NC2=CC=C(C(C(C3=C(F)C=CC(C(NC4CC4)=O)=C3)=O)=CN5)C5=N2)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
FGFR4-IN-24 関連分類
HY-179381 関連分類
Powered by Bioz